Julien Isoard

Chairman & CEO at SYnAbs
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Charleroi, Walloon Region, Belgium, BE
Languages
  • English -
  • French Native or bilingual proficiency

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

5.0

/5.0
/ Based on 2 ratings
  • (2)
  • (0)
  • (0)
  • (0)
  • (0)

Filter reviews by:

Brigitte Gay

Julien graduated first in his class at ESC Business School (Master in Biotechnology Management). He is extremely well trained both in biotechnology and in management. He is able in finance, project management and at the same time can rapidly respond to change as is needed today. He is currently Head of Business Development but also teaches at ESC Business School to help our students have the highest level possible. Julien is a hard worker, highly motivated, and has high standards when it comes to work.

Gilles MOUGIN

Julien was starting to improve himself outside biotech and moving to business. I was very efficient and then made good decision for his carreer.

You need to have a working account to view this content.
You need to have a working account to view this content.

Credentials

  • Content Marketing Foundations
    LinkedIn
    May, 2019
    - Oct, 2024
  • Content Marketing: Blogs
    LinkedIn
    May, 2019
    - Oct, 2024
  • Online Marketing Foundations
    LinkedIn
    Apr, 2019
    - Oct, 2024
  • Learning to Be Assertive
    LinkedIn
    Feb, 2019
    - Oct, 2024
  • Shane Snow on Storytelling
    LinkedIn
    Feb, 2019
    - Oct, 2024
  • Creativity Bootcamp
    LinkedIn
    Jan, 2019
    - Oct, 2024
  • Sales Prospecting
    LinkedIn
    Sep, 2018
    - Oct, 2024
  • Sales: Closing a Complex Sale
    LinkedIn
    Sep, 2018
    - Oct, 2024
  • Solution Selling
    LinkedIn
    Sep, 2018
    - Oct, 2024

Experience

    • Belgium
    • Biotechnology Research
    • 1 - 100 Employee
    • Chairman & CEO
      • Dec 2020 - Present

      SYnAbs' mission is to generate innovative antibodies against poor immunogenic compounds (steroids, small molecules, carbohydrates, epigenetic modifications) and complex membrane antigens (GPCR, ion channels, tyrosine kinase receptors, viral proteins) thanks to unique technologies (peptide immunization, syngeneic cell immunization, rat-LOU species, in-house adjuvant). Anti-drug antibodies, surrogates, or therapeutics mAbs in-vivo drug discovery platform, from antigen synthesis to gr manufacturing and antibody engineering. Click on https://www.synabs.be/custom-monoclonal-antibody-development to learn more. Show less

    • Business & Marketing Director
      • Mar 2016 - Nov 2020

    • Co-founder & Managing Director
      • Sep 2021 - Present

      Isy Invest is a holding company dedicated to the investment in start-up entities Isy Invest is a holding company dedicated to the investment in start-up entities

    • Belgium
    • Food & Beverages
    • 1 - 100 Employee
    • Co-Founder, Chairman
      • Mar 2015 - Present

      Facing the huge standardization of beers, we've decided to promote a custom approach and unique craft dedication, founding the ultimate Beer Manufacturing Organization. http://www.saint-lazare.be Facing the huge standardization of beers, we've decided to promote a custom approach and unique craft dedication, founding the ultimate Beer Manufacturing Organization. http://www.saint-lazare.be

    • Belgium
    • Biotechnology Research
    • Founder, Managing Director
      • Feb 2015 - Present

      Isy Bio is a consultancy firm dedicated to biotechnology organizations. We collaborate with them on interim management, business development, marketing strategy, and technology positioning. Isy Bio is a consultancy firm dedicated to biotechnology organizations. We collaborate with them on interim management, business development, marketing strategy, and technology positioning.

    • France
    • Research Services
    • 1 - 100 Employee
    • Member of the Investment Committee
      • Mar 2016 - May 2022

      Sayens is dedicated to technology transfer, maturation and valorization of inventions resulting from French research units through licensing deals and start-ups creation. Sayens is dedicated to technology transfer, maturation and valorization of inventions resulting from French research units through licensing deals and start-ups creation.

  • Freelance Biotech
    • Mons, Belgium
    • Founder, Managing Director
      • Jul 2018 - Feb 2021

      Freelance Biotech is the platform of freelance consultants, experts in the biotech industry. Freelance Biotech is the platform of freelance consultants, experts in the biotech industry.

    • France
    • Biotechnology Research
    • 1 - 100 Employee
    • Content Marketer
      • Apr 2019 - Nov 2020

      mAbexperts is a group based on complementary expertise with multidisciplinary know-how around products and services dedicated to the bioproduction of plasmid DNA and recombinant proteins. mAbexperts is a group based on complementary expertise with multidisciplinary know-how around products and services dedicated to the bioproduction of plasmid DNA and recombinant proteins.

    • Biotechnology Research
    • 1 - 100 Employee
    • Strategic Marketing Advisor
      • Nov 2017 - Sep 2020

      ImmunXperts offers services to support your drug development process, be it by mitigating risks through immunogenicity assessment or by saving time and money through custom in-vitro assay development. ImmunXperts offers services to support your drug development process, be it by mitigating risks through immunogenicity assessment or by saving time and money through custom in-vitro assay development.

    • Biotechnology
    • 1 - 100 Employee
    • Senior Business Advisor
      • Mar 2017 - Feb 2019

      Spectralys has developed unique expertise, through one single FTIR measurement in a couple of minutes, with limited sample volume (<50µg) and without the need for extensive sample pre-treatment, to retrieve information on critical parameters. Spectralys has developed unique expertise, through one single FTIR measurement in a couple of minutes, with limited sample volume (<50µg) and without the need for extensive sample pre-treatment, to retrieve information on critical parameters.

  • Amplycell
    • Liège Area, Belgium
    • Strategic Marketing Advisor
      • Mar 2015 - Aug 2017

      Risks that are linked to a stop of secretion are now banished. No change in your culture habits is required because BOOSTed and preBOOSTed cells can be cultured the same way as it is for the original cells, Cell Fitness is based upon a unique series of cell physical treatments. Risks that are linked to a stop of secretion are now banished. No change in your culture habits is required because BOOSTed and preBOOSTed cells can be cultured the same way as it is for the original cells, Cell Fitness is based upon a unique series of cell physical treatments.

    • Belgium
    • Research Services
    • 1 - 100 Employee
    • Senior Business Advisor
      • May 2015 - Aug 2016

      CER Groupe is a Belgian Preclinical CRO able to design a valuable and tailor-made solution for your in-vivo studies. Its main asset is to develop custom-made and flexible solutions, in an economic and timely manner for your R&D, GLP, and GMP-compliant animal studies. CER Groupe is a Belgian Preclinical CRO able to design a valuable and tailor-made solution for your in-vivo studies. Its main asset is to develop custom-made and flexible solutions, in an economic and timely manner for your R&D, GLP, and GMP-compliant animal studies.

  • ImmuneHealth
    • Charleroi Area, Belgium
    • Business & Marketing Director
      • Feb 2012 - Aug 2016

      ImmuneHealth is a global and flexible biomarker CRO, ables to design, set up, recruit, and conduct epidemiology studies for clinical biomarker panels validation, and provide immunomonitoring readouts (cell, gene and protein biomarkers) for clinical trials. ImmuneHealth is able to provide QC methods with development from scratch, testing, qualification, validation, technical transfer, consulting and training activies through ELISA, ELISpot, Multiplex, rt(q)PCR, sequencing, pyrosequencing, FACS, ICS, microneutralization, binding assays, CAPS... ImmuneHealth's laboratories are ISO, GCLP, and GMP compliant. To be counted among our partners, GSK Vaccines, Genticel, Neovacs, Celyad, Theravectys, MaSTherCell, Celogos, DIAsource, Volition Rx, Immune Targeting Systems, Kitozyme, Imcyse, Delphi Genetics, IPG, OncoDNA, Ovogenics, CareSquare, Cetic, Probiox, Novasep, DNAlytics, IMI, InnaVirVax, Promethera Biosciences, Euroscreen, PX Biosolutions, Xenikos, Novartis, Crucell... In September 2016, ImmuneHealth assets have been acquired by Caprion Biosciences. Show less

    • France
    • Higher Education
    • 300 - 400 Employee
    • Lecturer
      • Jan 2013 - Jun 2013

      - CMO market evolution - Negociation skills - Verbal and non-verbal communication - Long term partnership strategy and management - CMO market evolution - Negociation skills - Verbal and non-verbal communication - Long term partnership strategy and management

    • France
    • Chemical Manufacturing
    • 300 - 400 Employee
    • Bioprocessing Market Manager
      • Aug 2008 - Feb 2012

      Novasep Process, cGMP subsidiary of Novasep group, provides turn-key packages from early development to commercial manufacturing services for API & HP-API. HENOGEN S.A. is a cGMP BL2/BL3 multi-purpose Contract Manufacturing Organization ables to produce biologics through every expression system up to 1,000L scale from gene to clinical product phase III, including process flow-chart development, up-scale, potency assays, virus clearance scale-down study, QC method validation, F&F&F and final QP release. Henogen has a long expertise in biopharmaceutical field with projects including ; - virus vaccines (HSV, HIV, VZV, VSV, RSV, Influenza, HPV, MLV,...), - gene therapy (EIAV,..), - attenuated strains (Pertussis, Sonnei, Flexneri, Cholera,..), - monoclonal antibodies (anti-CD20, anti-CD28, anti-CD7, anti-CD3, anti-rhesusD, Hvv, ScFv), - recombinant proteins (LSA3, MSP1, MSP3, HLA, EPO,..), - dozens of MCB-WCB (E.Coli, L.lactis, CHO, MRC-5, Vero, HEK, BHK, NIH/3T3, NS0, YB2/0,…) and MVSS-DVSS - cytokines (GM-CSF, IL,TNF,INF,..) To be counted among our partners, Wyeth/Pfizer, GlaxoSmithKline, Oxford Biomedica, AVIR Green Hills Biotech, Pasteur, LFB,... Thesis: “Impacts of single-use bioreactor implementation on Biomanufacturing market and Organizations” Show less

    • France
    • Pharmaceutical Manufacturing
    • 1 - 100 Employee
    • Marketing And Development Intern
      • Jul 2006 - Feb 2007

      SFRI has accumulated and displayed, during its 25 years experience, a tremendous know how dedicated to haematology instruments and reagents. SFRI covers the whole spectrum of haematology needs : instruments, reagents, blood quality controls, spare parts, service and maintenance. Julien has developed an ELISA kit for isoflavones measurement in various kind of matrix from food ingredients to nutraceutic compounds. He was also in charge of market studies challenging HPL chromatography method, evaluate potential incomes and keeping an eye on regulatory authorities development.  Market research  Technology transfer  ELISA development and industrial customization Thesis: “Marketing and development for immunology kits” Show less

Education

  • Toulouse Business School
    Master of Business Administration - MBA, Business Administration and Management, General
    2007 - 2008
  • ENSTBB Bordeaux INP
    Master's degree, Biotechnology
    2005 - 2007

Community

You need to have a working account to view this content. Click here to join now